Previous close | 1.4000 |
Open | 1.2500 |
Bid | 1.2000 |
Ask | 1.5500 |
Strike | 45.00 |
Expiry date | 2024-12-20 |
Day's range | 1.2500 - 1.4000 |
Contract range | N/A |
Volume | |
Open interest | 3 |
Moderna said Monday its Covid/flu vaccine topped rivals from GSK and Sanofi, and its own Spikevax shot. But Moderna stock fell.
GSK's Arexvy becomes the first RSV vaccine approved for adults aged 50-59 who are at high risk.
Denali Therapeutics (DNLI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.